[Clinical study on effect of combined treatment of fuchunpian with radiotherapy on nasopharyngeal carcinoma].
The study based on the clinical prospective trial of 60 cases of nasopharyngeal carcinoma treated with combined treatment of radiotherapy and Fuchunpian in our hospital from September, 1988 to January, 1990. Results of clinical data of 5 years follow-up showed that Fuchunpian not only couldn't enhance the radiosensitivity of patients, but also increase the blood metastatic potency, the metastatic rate of patients treated with Fuchunpian (36.7%) was 2.67 times higher than that without it (10.0%). Therefore, it was considered that use Fuchunpian as a routine either administrated alone or combined with radiotherapy in treatment of nasopharyngeal carcinoma is not suitable.
Han
J Q
JQ
Shandong Institute of Tumor prevention, Jinan.
Chen
Y T
YT
Man
Y Y
YY
D000328:Adult; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000556:secondary; D002277:Carcinoma / Q000401:mortality / Q000556:secondary / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000556:secondary / Q000628:therapy; D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004311:Double-Blind Method; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary; D008175:Lung Neoplasms / Q000556:secondary; D008297:Male; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D011446:Prospective Studies
D000972:Antineoplastic Agents, Phytogenic; D003037:Cobalt Radioisotopes; D004365:Drugs, Chinese Herbal